SELEXIS
Selexis is a pioneering life sciences company and a global leader in mammalian (suspension-adapted CHO-K1) cell line generation, providing unparalleled proprietary technology and the highly-specialized expertise that is necessary to translate scientific innovation into life-saving medicines for patients.
SELEXIS
Industry:
Biotechnology Health Diagnostics
Founded:
2001-01-01
Address:
Plan-les-ouates, Geneve, Switzerland
Country:
Switzerland
Website Url:
http://www.selexis.com
Total Employee:
11+
Status:
Active
Contact:
(022) 308-9360
Email Addresses:
[email protected]
Total Funding:
67.48 K USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics Google Tag Manager Content Delivery Network Google Universal Analytics Font Awesome
Current Employees Featured
Yemi Onakunle
Yemi Onakunle VP, Licensing and Business Development @ Selexis VP, Licensing and Business Development 2011-12-01
Alberto Garotti
Alberto Garotti Chief Financial Officer @ Selexis Chief Financial Officer 2018-01-01
Pierre-Alain Girod
Pierre-Alain Girod CSO @ Selexis CSO
Marco Bocci
Marco Bocci VP, Licensing and Business Development @ Selexis VP, Licensing and Business Development
Regine Brokamp
Regine Brokamp COO @ Selexis COO
Founder
Igor Fisch
Sebastian Desimone
Investors List
Eurostars
Eurostars investment in Grant - Selexis
Foundation for Technological Innovation (FIT)
Foundation for Technological Innovation (FIT) investment in Debt Financing - Selexis
Newest Events participated
Participated in Biotech Week Boston 2019
on 2019-09-10 as sponsor
Participated in BioProcess International European Summit 2017
on 2017-04-25 as sponsor
Participated in Viral Safety 2017
on 2017-04-25 as sponsor
Participated in Cell Line Development & Engineering 2017
on 2017-04-24 as sponsor
Official Site Inspections
http://www.selexis.com
- Host name: 199.60.103.30
- IP address: 199.60.103.30
- Location: Canada
- Latitude: 43.6319
- Longitude: -79.3716
- Timezone: America/Toronto
Loading ...